Conditions: Pulmonary Arterial Hypertension
Keywords: Remodulin 6-Minute Walk Test
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 20
Healthy volunteers: no

Brief summary:
This was an open-label extension of Study RIV-PH-402, TRUST-1: Treprostinil for Untreated Symptomatic Pulmonary Arterial Hypertension (PAH) Trial. Subjects who completed Study RIV-PH-402 were eligible to enroll.

Detailed description:

Arms:
arm 1: Intravenous treprostinil was supplied as 1 mg/mL.

Interventions: intervention 1: Intravenous Treprostinil
Intervention descriptions: intervention 1: Intravenous treprostinil supplied in 20-mL vials and diluted to the appropriate concentration for administration.

Protocol document: